Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Polarean Imaging Plc | POLX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 3.28% | 1.575 | 09:01:16 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.60 | 1.575 | 1.625 | 1.525 |
| Industry Sector |
|---|
| PHARMACEUTICALS & BIOTECHNOLOGY |
| Top Posts |
|---|
Posted at 21/11/2024 08:36 by pre I hear GE has around 1/3 of US market in mri so that could be a big boost to Polx in terms of profit and sales revenue. They are clearly scaling up and getting some very big players in on the scene. |
Posted at 19/11/2024 07:37 by atmysignal Polx look a bit overbought here.Failed at its 50dma several times |
Posted at 18/11/2024 10:00 by moontheloon See mnight still pestering over at agl with constant polx bullet points. What as sad sack |
Posted at 15/11/2024 10:20 by m_night10 You waste your time and life moon. A few buys like the 740k you see now and it will go to 2p and then over with news faster than you can blink. :)POLX Polarean Imaging about to break out well above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at to 3.4p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 14/11/2024 09:11 by m_night10 POLX Polarean Imaging about to break out well above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at to 3.4p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 08/11/2024 08:36 by m_night10 POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 17/10/2024 15:19 by m_night10 POLX Mcap sub $20MIL right now I see it as a steal for Xenon MRI. No company debt, masssive growth potential, important best in class next generation MRI.1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout |
Posted at 02/10/2024 13:18 by john henry POLX being down 18% with the AIM all share down a few % is due to the fact theres been a large seller associated with POLX |
Posted at 26/9/2024 18:36 by m_night10 Also AGL fell from a £50m mcap now to like £25mcap. Watch it bounce back up again as always.POLX meanwhile is at a lowly £18mcap, barelt pricing in the cash and technology and revenues. Not only that the board are giving much more conservative guidance which so far it has delivered on, which is why when the interim results came a few weeks ago the price went UP. Unlike rampy Newland at Angle who consistent over promises and under delivers and thus a dump today. Not only that but POLX is set to have comparable revenues to ANGLE from a much lower market cap all whilst have more cash in the bank AND technology that is an easier sell to the clinical sites and they are coming in their droves. From 1.5p I fancy 5-6p EOY for POLX. |
Posted at 19/7/2024 10:09 by fft Errr. POLX are buying the older machines and selling them the newer ones. There is no mention of how much POLX are paying for them, and I suspect it is higher than the price POLX will get when they try and sell them again !This seems like a loss leader to get influential people involved. Note, there is no quote from the Virginia people saying how they always wanted the POLX kit. Indeed, unless I have looked at a wrong version of the RNS there is no quote at all In other words POLX are probably losing money on this deal and if other sites see this they may also like to do a trade in, but the more that do it the worse for POLX cash flow. My 2 cents |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
